Effective with dates of service on and after October 1, 2022, and in accordance with the IngenioRx* Pharmacy and Therapeutics (P&T) process, Empire BlueCross BlueShield will update its drug lists that support Commercial health plans.

 

Updates include changes to drug tiers and the removal of medications from the formulary.

 

Please note, this update does not apply to the Select Drug List and does not impact Medicaid and Medicare plans.

 

To ensure a smooth member transition and minimize costs, providers should review these changes and consider prescribing a drug on formulary or on a lower tier, if appropriate.

 

View a summary of changes here.

 

* IngenioRx, Inc. is an independent company providing pharmacy benefit management services and some utilization review services on behalf of Empire BlueCross BlueShield.

 

NYBCBS-CM-004629-22-CPN4461



Featured In:
September 2022 Newsletter